Publications
Preclinical characterization of vadadustat (AKB-6548), an oral small molecule hypoxia inducible factor prolyl-4-hydroxylase inhibitor, for the potential treatment of renal anemia. J Pharmacol Exp Ther. 10.1124/jpet.122.001126
(2022) NECAT
9700 S. Cass Ave.
Bldg. 436E
Lemont, IL 60439
630.252.0689
csalbego@cornell.edu
Copyright © 2025, NECAT
Design by FreeBiezz